Methicillin-Resistant Staphylococcal Infections

Chapter 103


Methicillin-Resistant Staphylococcal Infections



The rapid and widespread emergence of methicillin-resistant Staphylococcus spp. has led to infections that are among the more difficult diseases to treat in veterinary dermatology. Staphylococcus pseudintermedius is by far the most common species encountered in veterinary medicine. In dogs, the most common presentation of S. pseudintermedius infection is superficial pyoderma (and, less frequently, otitis, deep pyoderma, and surface pyoderma). These infections have been linked to poorly controlled allergic dermatitis, predominantly canine atopic dermatitis and other primary diseases that compromise the skin integrity and defense mechanisms.


Methicillin is a penicillin-type antibiotic that no longer is used in the treatment of patients. It also has been replaced in the laboratory by oxacillin for culture and susceptibility testing because it is unstable; thus oxacillin resistance is used as a marker for methicillin resistance of staphylococci. By convention, in vitro resistance to oxacillin implies resistance to all penicillins and cephalosporins (β-lactams), with the exception of some new-generation cephalosporins such as ceftobiprole and ceftaroline. Production of penicillin-binding protein 2a (PBP2a) by staphylococci confers methicillin resistance. These staphylococci carry the gene mecA that encodes the protein PBP2a.



Incidence


Historically, Staphylococcus intermedius was the most common bacteria isolated from cases of pyoderma. It has been shown, however, that most strains previously identified as S. intermedius actually are S. pseudintermedius, as shown through multilocus sequence typing (Bannoehr et al, 2007) (see Chapter 100).


The clinical presentation of superficial pyoderma caused by methicillin-resistant organisms generally does not differ from that of routine cases. However, it is the author’s experience that pyoderma caused by methicillin-resistant Staphylococcus aureus (MRSA) in dogs and cats differs markedly and characteristically is severe and deep. Articles have been published documenting methicillin resistance in cases of S. pseudintermedius infection (Cole et al, 2004; Gortel et al, 1999; Morris et al, 2006; Ruscher et al, 2010; Bryan et al, 2012). Interestingly, in another study only 2 of 57 S. intermedius isolates were resistant to methicillin; however, about half of the total expressed PBP2a, which indicates that the genetic capability was present to be resistant under more optimal conditions (Kania et al, 2004).


Since most of the public’s attention has been given to MRSA in animals, it is clear that there has been a definite increase in the number of reports of MRSA infections in pets (Baptiste et al, 2005; Gortel et al, 1999; Kania et al, 2004; Loeffler et al, 2005; Morris et al, 2006; Weese et al, 2010; Vitale et al, 2005). In addition to MRSA, Staphylococcus schleiferi recently has been associated with cases of canine pyoderma and has demonstrated methicillin resistance (May et al, 2005; Morris et al, 2006). MRSA and methicillin-resistant S. schleiferi infections appear to be uncommon in dogs. Many strains of methicillin-resistant Staphylococcus are not multidrug resistant.



Zoonosis


MRSA is considered to be a reverse zoonosis (human to animal transmission). There have been several documented cases of likely transmission of MRSA from humans to animals (Manian, 2003; O’Mahony et al, 2005; Tomlin et al, 1999; van Duijkeren et al, 2004; Weese et al, 2006). Transmission of MRSA to pets via contact with infected humans likely results in colonization (primarily nasal and rectal), infection, or both in dogs and cats. In addition, some of these reports have shown that pets can serve as a colonized or infected reservoir, which allows transmission back to the humans. The author has seen several cases of nasal colonization with MRSA in dogs that acted as a source of reinfection of humans who had intimate contact with the affected pet.

< div class='tao-gold-member'>

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 18, 2016 | Posted by in PHARMACOLOGY, TOXICOLOGY & THERAPEUTICS | Comments Off on Methicillin-Resistant Staphylococcal Infections

Full access? Get Clinical Tree

Get Clinical Tree app for offline access